Visit of the Pierre and Marie Curie Institute, whose staff conducts research on cancer control. Explanations on the functioning of the institute alternate with illustrations and photos of Pierre and Marie Curie.
Report devoted to the means implemented to fight against cancer. Several centres have been opened to detect, treat and investigate the causes of cancer. Animals are used as guinea pigs to advance the fight against cancer. High-tech devices are used to understand the mysteries of this disease.
The Antoine Lacassagne Centre in Nice celebrates its 50 years of existence, 50 years in the service of the fight against cancer and the management of patients. On February 4, World Cancer Day, focus on this Nice institution that over the years has continued to evolve and still intends to develop new projects.
The Paoli Calmettes Institute in Marseille is one of the 5 immunotherapy centres in France. Its officials have just made an assessment of their action and in particular of the use of a new substance, interlukine 2 which has high dose stimulates the immune system of the patient.
[Source France 3 Régions]: In Rennes, the Eugène Marquis Centre, dedicated to the fight against cancer, is distinguished by unparalleled results in the treatment of certain liver cancers. This innovative technology, which consists of injecting radioactive microbeads, is however still reimbursed in France. At present, it is the Eugène Marquis Centre and the manufacturer who take charge of the extra cost. The Eugène Marquis Centre has been using this cutting-edge technology regularly for 6 years. 200 patients from all over France were treated. Their inoperable liver cancer usually leaves them with little life expectancy and few therapeutic options. This radioembolization treatment consists of injecting radioactive glass microbeads as close as possible to the tumor. For this, the radiologist introduces a catheter through the femoral artery of the patient to the liver. The second phase of the intervention is to send the microbeads. In principle, a single injection is sufficient for treatment. Thanks to this treatment, nearly one cancer in 4 becomes operable. The survival time of patients increases to 24 months compared to 8 months with conventional chemotherapy. These results are due in particular to a very personalized support. When his liver cancer was diagnosed 3 years ago, Marcel Goupil had only 6 months to live. Now in remission, he is a grateful patient. The cost of treatment is 20,000 euros and is not covered by the health insurance. Health authorities review the claim.
Report devoted to the end of the mission of Professors Mayer and Pommateau, of the Léon Bérard Center, who had gone to South America to exchange with doctors on the fight against cancer.
[Source France 3 Régions]: Lung cancer is one of the most common and also one of the deadliest. In some patients, the combination of chemotherapy and immunotherapy, although effective, does not work. At the Georges François Leclerc centre in Dijon, an Inserm team is studying resistance to chemotherapy of tumour cells to modify their mechanisms. Research that earned him at the end of June an endowment of 75,000 euros by the Amgen Foundation to accelerate his work and find the treatment that will improve the chances of healing patients. The first human clinical trials could begin in 2022. Hope for the sick. Lung cancer causes more than 30,000 deaths each year.
Researchers at the Becquerel Centre in Rouen have highlighted the ability of a molecule to make cancer cells receptive to therapies. This discovery could open up prospects in the treatment of leukaemia. Animal testing could begin soon. For 20 years researchers have been working on the subject, today the laboratory of the Becquerel center is the only one in France to know how to cut this molecule. The next step is to show that this part of the molecule is able to penetrate the bone marrow and if accumulate in sufficient quantity.
[Source France 3 Régions]: Toulouse at the forefront of the fight and research against cancer... New example with this world premiere realized at the oncopole... A revolutionary treatment for melanoma... It is actually to add an anti-inflammatory to the treatment to increase its effectiveness tenfold... Explanations
In Caen, the cancer centre François BACLESSE receives 4600 patients every year. It is a reference institution in France, especially thanks to the psychological support pole. In Lower Normandy, cancer kills nearly 4,000 people a year, and is cured in more than one out of two cases, thanks to the increasingly early detection. The BACLESSE Centre will now be part of the ANCELOT network, intended to connect all health stakeholders (from doctor to hospital) in order to offer patients the best chance of recovery.
Fusion... To constitute a pole of excellence in the fields of cancer control. More attractive to the pharmaceutical industry, the Institut de Cancérologie de l'Ouest can thus claim more substantial funding for its research. It will also become the first radiotherapy center in France, as well as the first center for breast reconstruction. The Alliance will promote the development of activities. Each of the medical teams, while remaining on its own site, will benefit from each other’s experiences. But it is above all the patient, who will be the great beneficiary of the merger of the two centers.
[Source France 3 Régions]: Who doesn’t know the Alexis Vautrin centre in Nancy? a well-known cancer centre that has been renamed the Institut de Cancérologie de Lorraine to better meet the challenges of tomorrow overview of what is being done in this new institution ITW Pr Didier Peiffert ( Head of Radiotherapy Department, Lorraine Cancer Institute): technologies are progressing very rapidly to have ever more precision in order to be able to better target the tumor and better protect the organs that do not need to be irradiated; improvement in terms of tumor healing and patient tolerance to irradiation ITW Pr Jean Louis Merlin (Head of Tumour Biology Unit, Institut de cancérologie de Lorraine): Mr X’s cancer and Mr Y’s cancer should no longer be treated in the same way, with greater chances of recovery: this is called tumor mutation DNA profiles
[Source France 3 Régions]: Calypso! Behind this pretty name hides a new treatment for prostate cancer. The highly targeted technique is innovative. The waves attack the tumor and exclusively the tumor thanks to a GPS system: What limit the side effects of radiotherapy.
2567-mo/ INSERM Clermont has made two discoveries in the fight against skin cancer: discovery of a molecule to better identify melanoma and discovery of a new drug: cystemustine. They will improve the life expectancy of patients. INSERM works in direct contact with the Jean PERRIN centre. In September, its buildings will expand.
The visit of Roselyne BACHELOT in Lille this morning. The Minister of Health travels to a region where the health of the inhabitants is the worst in France. She went through the emergency department of the Regional Hospital Center, before going to inaugurate a revolutionary equipment at the anti-cancer center of Oscar Lambret. This articulated giant arm should revolutionize the treatment of cancers. Inaugurated at no charge by Roselyne BACHELOT, the Cyberknife will change the lives of thousands of patients. This first tumor treatment robot is fully automated and ultra-precise. Xavier MIRABEL, Doctor at the Oscar Lambret Center: "it is a radiotherapy machine that brings a real technological renewal because it gives extreme precision, usable on moving targets. The interest is to find new avenues of treatment for patients for whom we were quite destitute. ' 40 patients have already benefited from the Cyberknife since its commissioning 3 months ago. Faster and less cumbersome treatment since it does not require hospitalization. Eric LARTIGAU, head of the radiotherapy department of the Oscar Lambret center: "for the preparation, the patient will come, will benefit from a scanner and will then return for the treatment sessions, without hospitalization." There are currently only three machines like this one in France. The region that has financed nearly half of the 6 million euros of the Cyberknife wants to lose its sad record of some cancers and save some of the 10,000 patients who die each year in the region.
[Source France 3 Régions]: As part of Operation Pink October, twenty women who have had breast cancer try the practice of canoeing surrounded by caregivers on Lake Bordeaux. Objective: create a section dedicated to these women at the nauitic center of Bordeaux Lac. This sport is particularly suitable for women with breast surgery. The canoe kayak prevents all rheumatic problems and post-surgical inflammatory phenomena. Studies have shown that adequate physical activity prevents 50% of breast cancer relapses.
Reportage. The medical team of the Sainte-Catherine clinic in Avignon has been trained and supported for several years by a psychiatrist in order to better manage the difficult situations that nursing staff may face. Alternately, commentary on factual images and interviews with Professor Daniel SERIN; by Dr Isabelle PIOLLET; by a paramedic Jean HOUELLEBEC.
On the occasion of the National Days of the French Society of Allergology and Immunology in Reims, presentation of the ongoing research work within the GODINOT Institute, pioneer in the fields of cell therapy, work which gives rise to new hopes for patients with certain cancers with the implementation of new therapies; interview with Dr Jean-Christophe Eymard, oncologist at the GODINOT institute and Professor KOCHMAN, director of the GODINOT institute.
Presentation by Mr LONGCHAMBON, Secretary of State for Scientific Research, on the nuclear industry in the service of health. Images shot in an anti-cancer institute illustrate how atomic energy can be used to cure certain diseases, such as deep tumors, thanks to an electric accelerator.
The INA Galaxy 
